Clareo Health | Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
Patients who have undergone primary NSCLC radical surgery or SBRT treatment;
Complete systemic lesion imaging assessment before primary NSCLC radical surgery or SBRT treatment (Note: Tumor size ≥ 3 cm or centrally located tumor requires PET/CT and/or invasive mediastinal staging);
Patients willing to cooperate with the follow-up after primary NSCLC radical surgery;
informed consent of the patient.
You may not be if
Poor quality of computed tomography imaging;
Baseline imaging shows pure ground-glass nodules (GGO);
Uncontrolled epilepsy, central nervous system disease, or history of mental disorders, judged by the researcher to potentially interfere with the signing of the informed consent form or affect patient compliance.;
